Page last updated: 2024-08-21

canrenone and Cirrhosis

canrenone has been researched along with Cirrhosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Adair, CD; Agalakova, NI; Bagrov, AY; Ershov, IA; Grigorova, YN; Mikhailova, EV; Nadei, OV; Reznik, VA; Romanova, IV; Romanova, LA; Samuilovskaya, L	1
Boccanelli, A; Clemenza, F; Conaldi, PG; Di Carlo, D; Di Lenarda, A; Gonzini, L; Latini, R; Lucci, D; Maggioni, AP; Masson, S; Mureddu, GF; Nicolis, EB; Vanasia, M	1
Bagrov, AY; Bagrov, KA; Emelianov, IV; Fedorova, OV; Frolova, EV; Grigorova, YN; Juhasz, O; Konradi, AO; Lakatta, EG; Marshall, CA; Wei, W	1

Trials

1 trial(s) available for canrenone and Cirrhosis

Article	Year
Galectin-3 and the Mineralocorticoid Receptor Antagonist Canrenone in Mild Heart Failure. Circulation journal : official journal of the Japanese Circulation Society, 2017, Sep-25, Volume: 81, Issue:10 Topics: Aged; Biomarkers; Blood Proteins; Canrenone; Female; Fibrosis; Galectin 3; Galectins; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prognosis; Treatment Outcome	2017

Article

Year

Galectin-3 and the Mineralocorticoid Receptor Antagonist Canrenone in Mild Heart Failure.

Circulation journal : official journal of the Japanese Circulation Society, 2017, Sep-25, Volume: 81, Issue:10

Topics: Aged; Biomarkers; Blood Proteins; Canrenone; Female; Fibrosis; Galectin 3; Galectins; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prognosis; Treatment Outcome

2017

Other Studies

2 other study(ies) available for canrenone and Cirrhosis

Article	Year
Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia. International journal of molecular sciences, 2022, Mar-19, Volume: 23, Issue:6 Topics: Animals; Bufanolides; Canrenone; Collagen Type I; Female; Fibrosis; Humans; Mineralocorticoid Receptor Antagonists; Pre-Eclampsia; Pregnancy; Rats; Sodium-Potassium-Exchanging ATPase; Vasodilation	2022
Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists. Journal of hypertension, 2015, Volume: 33, Issue:8 Topics: Animals; Aorta; Arterial Pressure; Bufanolides; Canrenone; Cells, Cultured; Collagen Type I; Endothelin-1; Erythrocytes; Female; Fibrosis; Humans; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitroprusside; Pulse Wave Analysis; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Spironolactone; Vasodilator Agents	2015

Article

Year

Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia.

International journal of molecular sciences, 2022, Mar-19, Volume: 23, Issue:6

Topics: Animals; Bufanolides; Canrenone; Collagen Type I; Female; Fibrosis; Humans; Mineralocorticoid Receptor Antagonists; Pre-Eclampsia; Pregnancy; Rats; Sodium-Potassium-Exchanging ATPase; Vasodilation

2022

Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.

Journal of hypertension, 2015, Volume: 33, Issue:8

Topics: Animals; Aorta; Arterial Pressure; Bufanolides; Canrenone; Cells, Cultured; Collagen Type I; Endothelin-1; Erythrocytes; Female; Fibrosis; Humans; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitroprusside; Pulse Wave Analysis; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Spironolactone; Vasodilator Agents

2015